Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine.

[1]  J. Stockigt.  Clinical Strategies in the Testing of Thyroid Function , 2011 .

[2]  J. Stockigt.  Thyroid Hormone Binding and Variants of Transport Proteins , 2010 .

[3]  R. Weiss,et al.  Syndromes of Reduced Sensitivity to Thyroid Hormone , 2010 .

[4]  L. Braverman,et al.  Free T4 immunoassays are flawed during pregnancy. , 2009, American journal of obstetrics and gynecology.

[5]  B. Wolffenbuttel,et al.  Interference from heterophilic antibodies in seven current TSH assays , 2008, Annals of clinical biochemistry.

[6]  B. Mendonca,et al.  Effects of long-term storage of filter paper blood samples on neonatal thyroid stimulating hormone, thyroxin and 17-alpha-hydroxyprogesterone measurements , 2008, Journal of medical screening.

[7]  A. Rockwood,et al.  Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction--liquid chromatography/tandem mass spectrometry. , 2008, Clinical chemistry.

[8]  L. Thienpont.  A major step forward in the routine measurement of serum free thyroid hormones. , 2008, Clinical chemistry.

[9]  S. Refetoff,et al.  Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. , 2007, Best practice & research. Clinical endocrinology & metabolism.

[10]  G. Van den Berghe,et al.  Changes within the thyroid axis during the course of critical illness. , 2006, Endocrinology and metabolism clinics of North America.

[11]  J. Wass,et al.  Oxford Handbook of Endocrinology and Diabetes , 2002 .

[12]  K. Nustad,et al.  Immunometric assay interference: incidence and prevention. , 2002, Clinical chemistry.

[13]  K. Mann,et al.  Characterization of T(4)-binding globulin cleaved by human leukocyte elastase. , 2002, The Journal of clinical endocrinology and metabolism.

[14]  J. Abucham,et al.  Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. , 2001, The Journal of clinical endocrinology and metabolism.

[15]  J. Michl,et al.  A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. , 2000, The Journal of clinical endocrinology and metabolism.

[16]  L J Kricka,et al.  Interferences in immunoassay--still a threat. , 2000, Clinical chemistry.

[17]  B. Goichot,et al.  Intermethod discordant free thyroxine measurements in bone marrow-transplanted patients. , 2000, Clinical chemistry.

[18]  G. Van den Berghe,et al.  Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.

[19]  N. Christofides.  Furosemide interference in newer free thyroxine assays. , 1999, Clinical chemistry.

[20]  R. B. Wilcox,et al.  Salsalate administration--a potential pharmacological model of the sick euthyroid syndrome. , 1998, The Journal of clinical endocrinology and metabolism.

[21]  E. Reece,et al.  Free fatty acids and insulin resistance during pregnancy. , 1998, The Journal of clinical endocrinology and metabolism.

[22]  S. Katayama,et al.  Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure , 1998, Clinical endocrinology.

[23]  I. Young,et al.  Misleading serum free thyroxine results during low molecular weight heparin treatment. , 1998, Clinical chemistry.

[24]  N. Després,et al.  Antibody interference in thyroid assays: a potential for clinical misinformation. , 1998, Clinical chemistry.

[25]  G. Van den Berghe,et al.  Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. , 1998, The Journal of clinical endocrinology and metabolism.

[26]  T. Badrick,et al.  Heterophilic antibodies remain a problem for the immunoassay laboratory. , 1997, American journal of clinical pathology.

[27]  J. Stockigt,et al.  Thyroid Hormone Transport , 1997 .

[28]  A. Weetman,et al.  Pharmacotherapeutics of the Thyroid Gland , 1997, Handbook of Experimental Pharmacology.

[29]  M. Surks,et al.  Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved. , 1996, JAMA.

[30]  J. Jaume,et al.  Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis. , 1996, Thyroid : official journal of the American Thyroid Association.

[31]  M. Sabljar-Matovinović,et al.  Thyroid hormone metabolism and thyroid diseases in chronic renal failure. , 1996, Endocrine reviews.

[32]  M. Surks,et al.  Drugs and thyroid function. , 1995, The New England journal of medicine.

[33]  M. Cruz-Ruíz,et al.  Evaluation of AutoDELFIA and access automated immunoassay systems for third generation assays for thyrotropin. , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[34]  P. Beck‐Peccoz,et al.  Variable biological activity of thyroid-stimulating hormone. , 1994, European journal of endocrinology.

[35]  T. Mckenna,et al.  Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies , 1994, Clinical endocrinology.

[36]  C. Lim,et al.  A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum. , 1993, Metabolism: clinical and experimental.

[37]  J. Brunzell,et al.  Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. , 1993, Journal of lipid research.

[38]  R. Ekins.  The free hormone hypothesis and measurement of free hormones. , 1992, Clinical chemistry.

[39]  C. Lim,et al.  Interactions between oleic acid and drug competitors influence specific binding of thyroxine in serum. , 1991, The Journal of clinical endocrinology and metabolism.

[40]  C. Laughton,et al.  Inability to detect an inhibitor of thyroxine-serum protein binding in sera from patients with nonthyroid illness. , 1991, Metabolism: clinical and experimental.

[41]  E. Roti,et al.  Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns , 1991, Journal of endocrinological investigation.

[42]  R. Ekins.  Measurement of free hormones in blood. , 1990, Endocrine reviews.

[43]  J. E. Midgley,et al.  Low-normal concentrations of free thyroxin in serum in late pregnancy: physiological fact, not technical artefact. , 1989, Clinical chemistry.

[44]  D. Craik,et al.  Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin. , 1989, The Journal of clinical endocrinology and metabolism.

[45]  H. Yki-Järvinen,et al.  Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations. , 1989, The Journal of clinical endocrinology and metabolism.

[46]  M. Surks,et al.  Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis. , 1988, The Journal of clinical endocrinology and metabolism.

[47]  C. Lim,et al.  Drug and fatty acid effects on serum thyroid hormone binding. , 1988, The Journal of clinical endocrinology and metabolism.

[48]  S. Kunitake,et al.  Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. , 1987, The Journal of clinical endocrinology and metabolism.

[49]  J. Stockigt,et al.  EFFECT OF ORAL FRUSEMIDE ON DIAGNOSTIC INDICES OF THYROID FUNCTION , 1987, Clinical endocrinology.

[50]  C. Mendel,et al.  Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin. , 1986, The Journal of clinical endocrinology and metabolism.

[51]  C. Lim,et al.  Non‐isotopic spectrophotometric determination of the unbound fraction of drugs in serum * , 1986, The Journal of pharmacy and pharmacology.

[52]  D. Solomon,et al.  The role of thyroxine (T4)-binding serum proteins in oleic acid-induced increase in free T4 in nonthyroidal illnesses. , 1986, The Journal of clinical endocrinology and metabolism.

[53]  D. Solomon,et al.  Serum thyroid hormone binding inhibitor in nonthyroidal illnesses. , 1986, Metabolism: clinical and experimental.

[54]  K. Miura,et al.  Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment, and pathogenesis. , 1985, Annals of internal medicine.

[55]  P. Hamblin,et al.  Interaction of furosemide with serum thyroxine-binding sites: in vivo and in vitro studies and comparison with other inhibitors. , 1985, The Journal of clinical endocrinology and metabolism.

[56]  C. Lim,et al.  High concentrations of furosemide inhibit serum binding of thyroxine. , 1984, The Journal of clinical endocrinology and metabolism.

[57]  M. Cattaneo,et al.  Evaluation of free thyroxine methods in the presence of iodothyronine-binding autoantibodies. , 1984, The Journal of clinical endocrinology and metabolism.

[58]  J. Stockigt,et al.  "Unbound analog" radioimmunoassays for free thyroxin measure the albumin-bound hormone fraction. , 1983, Clinical chemistry.

[59]  J. Corrie,et al.  Immunoassays for clinical chemistry , 1983 .

[60]  K. Sterling,et al.  Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation. , 1966, The Journal of clinical investigation.